Product Information
TRI-SPRINTEC TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1286 per EA under NDC 00555901858. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555901858
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075808On Market Since
12/29/2003
Price Statistics
The NADAC for TRI-SPRINTEC TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1286 per EA |
|---|---|
| All-time high | $0.3811 (Apr 16, 2014) |
| All-time low | $0.1072 (Jul 17, 2024) |
| 52-week high | $0.1375 |
| 52-week low | $0.1286 |
| Median price | $0.1967 |
| Average price | $0.2194 |
| Largest weekly change | -19.9% (Jul 17, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI-SPRINTEC TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-SPRINTEC TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1286 per EA (NDC 00555901858), effective Jun 24, 2026.
How has the price of TRI-SPRINTEC TABLET changed over time?
Over the history we have for it, the NADAC for TRI-SPRINTEC TABLET has declined 62.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRI-SPRINTEC TABLET?
Since Nov 28, 2013, the NADAC for TRI-SPRINTEC TABLET has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.3811 (Apr 16, 2014), with a median of $0.1967 per EA.
Are there cheaper alternatives to TRI-SPRINTEC TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRI-LO-MARZIA TABLET, is $0.1049 per EA — about 18% below TRI-SPRINTEC TABLET.
Who manufactures TRI-SPRINTEC TABLET?
TRI-SPRINTEC TABLET (NDC 00555901858) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification